Erlander Mark 4
4 · Cardiff Oncology, Inc. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Erlander Mark
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2020-06-17+221,241→ 380,200 totalExercise: $2.60Exp: 2030-06-17→ Common Stock (221,241 underlying)
Footnotes (1)
- [F1]73,747 vest on each of 6/17/2021, 2022 and 2023.